Quantcast

Latest Clinical trial Stories

2014-05-20 16:27:10

- Pooled Efficacy Analyses from Phase 3 ASCEND and CAPACITY Studies Presented at 2014 American Thoracic Society Meeting - SAN DIEGO, May 20, 2014 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that results of analyses of pooled data from the ASCEND trial and the two previous Phase 3 CAPACITY trials evaluating pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) were presented at the 2014 International Conference of the American Thoracic Society (ATS) in San Diego,...

2014-05-20 16:25:38

PRINCETON, N.J., May 20, 2014 /PRNewswire-USNewswire/ -- Health care researchers, health technology assessors, manufacturers, governments, and patients will examine the role of "Big Data" in health care decision making at the ISPOR 19th Annual International Meeting. The meeting will take place May 31 - June 4, 2014 at the Palais des Congrès de Montréal in Montréal, Québec, Canada. http://photos.prnewswire.com/prnvar/20131001/DC88062LOGO The first plenary session, "The Use of "Big Data"...

2014-05-20 12:10:40

University of Texas Health Science Center at San Antonio Recruiting more Hispanics to cancer clinical trials crucial to reducing health disparities Hispanics are the fastest-growing demographic group in the United States, and they suffer from major health disparities, including higher rates of cancers of the cervix, stomach and liver. However, their enrollment levels in cancer clinical trials seeking to cure these problems is abysmally low: 3.9 percent. In a paper published today...

2014-05-20 08:32:11

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, May 20, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts' notes regarding Gilead Sciences, Inc. (NASDAQ: GILD), Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) and Puma Biotechnology, Inc. (NYSE: PBYI). Private wealth members receive these notes ahead of publication. To reserve...

2014-05-20 08:31:26

Technology solution designed to improve monitoring effectiveness and efficiency BOSTON, May 20, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced the launch of its Perceptive MyTrials®( )Data-Driven Monitoring solution. Developed by PAREXEL Informatics, it is a key component of the Perceptive MyTrials eClinical platform, an integrated suite of applications for managing clinical trials. On-site...

2014-05-19 23:05:14

PharmApprove President Dr. Laurie Smaldone to Moderate Panel of Regulatory Experts at the BIO International Conference in San Diego, CA Lawrenceville, NJ (PRWEB) May 19, 2014 PharmApprove – the leading strategic, regulatory and scientific communication consultancy to the pharmaceutical and biotechnology industries – announces plans for an interactive session on FDA communications at the 2014 BIO International Convention in San Diego. Dr. Laurie Smaldone, PharmApprove President and...

2014-05-19 08:29:29

Webinar May 22nd Discusses Advanced Techniques in Clinical Trial Patient Engagement BURLINGTON, Mass., May 19, 2014 /PRNewswire/ -- inVentiv Clinical Trial Recruitment Solutions (iCTRS), created to efficiently and predictably accelerate trials, will host a webinar next Thursday for clinical trial sponsors on "Using Behavioral Science to Engage Clinical Trial Participants." The one-hour webinar on May 22, 2014 begins at 1:30 p.m. EDT. Those interested in participating may register today on the...

2014-05-19 08:28:29

SAN FRANCISCO, May 19, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a biopharmaceutical company developing novel pain and cancer therapeutics, announced that Ivan Gergel, M.D., will serve as the Company's new Senior Vice President, Drug Development & Chief Medical Officer effective today. Dr. Gergel will have oversight for the company's clinical strategy and activities, including direct supervision of clinical research, clinical operations, medical affairs, regulatory...

2014-05-18 23:01:41

RnRMarketResearch.com adds “Metabolic Acidosis Global Clinical Trials Review, H1, 2014” to its store. Order a Purchase copy at http://www.rnrmarketresearch.com/contacts/purchase?rname=176883. Dallas, Texas (PRWEB) May 18, 2014 “Metabolic Acidosis Global Clinical Trials Review, H1, 2014″ provides data on the Metabolic Acidosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metabolic Acidosis. It includes an overview...

2014-05-18 16:20:29

- Investor Conference Call and Webcast Today at 8 p.m. EDT (5 p.m. PDT) - BRISBANE, Calif., May 18, 2014 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today reported that results from the Phase 3 ASCEND study evaluating pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) were presented today at the International Conference of the American Thoracic Society (ATS) in San Diego, and published on-line in the New England Journal of Medicine. Dr. Talmadge King, Professor and...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related